Riskpilot← Back to searchSign inGet full accessHälsa inifrån & ut ER AB
ABActiveOrg 5593141913Odengatan 6Hospital activities · NACE 8610Est. 20210 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
-270200.0%
-100% vs 2023
Equity ratio
55.6%
Financial strength
Net profit 2024
SEK 77K
-79% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK 3K | -100% |
| Net profit | SEK 77K | -79% |
| Total assets | SEK 520K | -58% |
| Equity | SEK 289K | -30% |
| Employees | 0 | — |
Legal name
Hälsa inifrån & ut ER AB
Org number
5593141913
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
26 april 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska arbeta med hälsa och sjukvård. Konsulting kommer att ske inom sexuell, reproduktiv hälsa samt vård och omsorg. Med ett helhetsperspektiv på hälsa kommer det även erbjudas träning för både den fysiska men också för den mental hälsan.
Address
Odengatan 6
Email
rova_2@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 547 | 977 | 1 263 | −0 |
| Staff expenses | — | −773 | −631 | 13 |
| EBITDA | 296 | 167 | 607 | 3 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 296 | 167 | 607 | 3 |
| Net financials | −1 | −0 | 1 | 22 |
| Profit before tax | 222 | 125 | 456 | 98 |
| Tax | −46 | −26 | −94 | −21 |
| Net profit | 176 | 99 | 362 | 77 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 478 | 741 | 1 232 | 520 |
| Equity | 201 | 200 | 412 | 289 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 204 | 426 | 553 | 38 |
| Total debt | 204 | 426 | 553 | 38 |
EBITDA margin
270200.0%
This company
15.8%
Market median
+1710027% vs market
20212024
Equity ratio
55.6%
This company
38.2%
Market median
+46% vs market
20212024
Return on equity
26.8%
This company
18.4%
Market median
+46% vs market
20212024
Net profit margin
7744100.0%
This company
8.1%
Market median
+95606073% vs market
20212024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20212024
Debt / equity
0.80×
This company
0.62×
Market median
+29% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-04-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hälsa inifrån & ut ER AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Astrid Veronica Persson | Deputy Board Member | 0 companies |
| Maria Elin Eufemia Rova | Board of Directors | 0 companies |